Kodi-M Co Ltd (224060) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kodi-M Co Ltd (224060) has a cash flow conversion efficiency ratio of -0.038x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-178.62 Million ≈ $-121.05K USD) by net assets (₩4.71 Billion ≈ $3.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 224060 stock market capitalisation for the company's overall valuation and market capitalisation.
Kodi-M Co Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Kodi-M Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kodi-M Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kodi-M Co Ltd ranked by their cash flow conversion efficiency. Explore Kodi-M Co Ltd (224060) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanil Chemical Ind. Co. Ltd
KQ:007770
|
-0.034x |
|
Metacon AB
ST:META
|
-0.611x |
|
Southern Fertilizer JSC
VN:SFG
|
0.325x |
|
Spacenet Enterprises India Limited
NSE:SPCENET
|
0.036x |
|
Caravelle International Group
NASDAQ:HTCO
|
0.505x |
|
London City Equities Ltd
AU:LCE
|
-0.198x |
|
American Pacific Mining Corp
F:1QC1
|
-0.048x |
|
Leyand International Tbk
JK:LAPD
|
0.140x |
Annual Cash Flow Conversion Efficiency for Kodi-M Co Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Kodi-M Co Ltd from 2015 to 2025. View Kodi-M Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩10.75 Billion ≈ $7.29 Million |
₩-3.68 Billion ≈ $-2.49 Million |
-0.342x | -190.56% |
| 2024-12-31 | ₩45.19 Billion ≈ $30.63 Million |
₩-5.32 Billion ≈ $-3.60 Million |
-0.118x | +42.92% |
| 2023-12-31 | ₩32.17 Billion ≈ $21.80 Million |
₩-6.63 Billion ≈ $-4.49 Million |
-0.206x | +43.10% |
| 2022-12-31 | ₩46.97 Billion ≈ $31.83 Million |
₩-17.02 Billion ≈ $-11.53 Million |
-0.362x | -86.76% |
| 2021-12-31 | ₩55.69 Billion ≈ $37.74 Million |
₩-10.80 Billion ≈ $-7.32 Million |
-0.194x | +31.34% |
| 2020-12-31 | ₩79.93 Billion ≈ $54.17 Million |
₩-22.59 Billion ≈ $-15.31 Million |
-0.283x | +8.88% |
| 2019-12-31 | ₩65.51 Billion ≈ $44.39 Million |
₩-20.31 Billion ≈ $-13.77 Million |
-0.310x | -1368.33% |
| 2018-12-31 | ₩56.29 Billion ≈ $38.15 Million |
₩1.38 Billion ≈ $932.73K |
0.024x | +288.85% |
| 2017-12-31 | ₩55.27 Billion ≈ $37.45 Million |
₩-715.52 Million ≈ $-484.90K |
-0.013x | +97.41% |
| 2016-12-31 | ₩15.85 Billion ≈ $10.74 Million |
₩-7.91 Billion ≈ $-5.36 Million |
-0.499x | -377.13% |
| 2015-12-31 | ₩12.28 Billion ≈ $8.32 Million |
₩2.21 Billion ≈ $1.50 Million |
0.180x | -- |
About Kodi-M Co Ltd
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and chang… Read more